29.10.2014 Views

February 27, 2012 - IMM@BUCT

February 27, 2012 - IMM@BUCT

February 27, 2012 - IMM@BUCT

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BUSINESS<br />

firm has been upgrading its labs. Lubrizol<br />

was purchased in September 2011 by Berkshire<br />

Hathaway, a conglomerate controlled<br />

by billionaire investor Warren Buffett.<br />

FMC is slating a nearly 5% increase in<br />

R&D spending this year. The firm plans to<br />

direct funds across its product lines, which<br />

include agricultural chemicals, specialty<br />

chemicals such as lithium for car batteries,<br />

and industrial products. NewMarket, the<br />

parent of fuel additives maker Ethyl and<br />

lubricant oil additives maker Afton Chemical,<br />

also plans a nearly 5% increase in R&D.<br />

BASF , the chemical industry’s largest<br />

R&D spender in absolute terms, is not in<br />

this year’s survey because it provided its<br />

R&D spending plans too close to C&EN<br />

press time to be included in the analysis.<br />

However, it plans to spend nearly $2.4 billion<br />

on research this year, up 5.9% compared<br />

with 2011. The rate at which BASF plans to<br />

increase spending is more than twice that<br />

of the largest R&D spender in the survey,<br />

DuPont, which plans a 2.2% increase to $2.0<br />

billion. A BASF spokesman explains that the<br />

firm continues to increase R&D spending as<br />

it emphasizes growth through innovation.<br />

Other surveys of spending plans also find<br />

that chemical makers are cautiously increasing<br />

future-oriented investments. According<br />

to the economics and statistics department<br />

of the industry group American Chemistry<br />

Council (ACC), high energy prices, the debt<br />

crisis in Europe, a slowdown in economic<br />

growth in China, and last year’s earthquake<br />

in Japan all contributed to a global soft patch<br />

centered in manufacturing.<br />

In the future, ACC economists say, developed<br />

nations will continue to grow slowly<br />

while emerging markets grow more rapidly<br />

because of industrialization and consumerdriven<br />

demand. As a result, 90% of yearover-year<br />

increases in chemical industry<br />

capital spending will be directed to emerging<br />

markets between now and 2016.<br />

The trade association’s fall survey<br />

of the chemistry enterprise found that<br />

global capital spending by chemical firms<br />

increased 10.0% to $511 billion in 2011 and<br />

should rise 9.0% to $557 billion in <strong>2012</strong>. By<br />

2016, ACC predicts, the global industry’s<br />

capital spending will reach more than<br />

$800 billion.<br />

In the U.S., ACC’s survey found, capital<br />

spending rose 7.0% in 2011 to $29.4 billion,<br />

and it will rise an additional 7.3% this year<br />

to $31.5 billion. Much of the spending will<br />

go toward replacing worn-out plants and<br />

equipment. Moving ahead, the economists<br />

say, the development of shale gas will be a<br />

game changer that will lead to new investments<br />

in petrochemicals and derivatives.<br />

When it comes to R&D, ACC’s survey<br />

found that U.S. chemical firms increased<br />

R&D budgets by 3.5% in 2011 to $57.4 billion<br />

and plan to increase spending another<br />

4.0% in <strong>2012</strong> to $59.7 billion. The survey<br />

includes pharmaceutical research spending,<br />

which the group says will rise at a faster<br />

pace than nonpharmaceutical spending.<br />

TAKING A GLOBAL perspective, the “<strong>2012</strong><br />

Global R&D Funding Forecast,” put together<br />

by R&D Magazine and the nonprofit<br />

research group Battelle , predicts that<br />

worldwide R&D spending by all industries<br />

will grow 5.2% in <strong>2012</strong> to $1.4 trillion. Asian<br />

countries, according to the report, are leading<br />

the growth with an 8.6% increase in<br />

spending. European R&D will grow by 3.5%,<br />

and U.S. spending will rise 2.1%.<br />

TECHNOLOGY<br />

R&D In Emerging Countries Comes With Risks And Rewards<br />

As chemical firms increased their R&D<br />

spending over the past decade, many of<br />

them enlarged their research capabilities<br />

in developing countries. Those overseas<br />

investments have helped companies gain<br />

market share and increase profits, but<br />

they are not without risk.<br />

Dow Chemical has about 900 people<br />

working in R&D labs in Asia, with the largest<br />

contingent, roughly 500 people, in<br />

Shanghai. Having experts on the ground<br />

in a region that has become a manufacturing<br />

powerhouse means Dow can better<br />

contour products for the local market, according<br />

to William F. Banholzer, the firm’s<br />

chief technology officer (CTO). “You can’t<br />

solve Asian customers’ problems from<br />

the U.S.,” he says.<br />

Just about all of Dow’s researchers in<br />

China are native to the region. Their familiarity<br />

with local markets has helped Dow<br />

develop coatings materials, for instance,<br />

that reduce airborne formaldehyde, a<br />

lung irritant and probable carcinogen that<br />

is still widely used in industrial processes<br />

in China.<br />

Banholzer acknowledges that he worries<br />

about intellectual property (IP) theft<br />

in developing countries in which legal protections<br />

may not be as robust as in more<br />

developed ones. But he points out that<br />

IP theft occurs in developed countries<br />

too. For instance, Kexue Huang, a Dow<br />

researcher who was based in Indianapolis,<br />

recently pleaded guilty in a U.S. court to<br />

stealing Dow technology for making the<br />

insecticide Spinosad (C&EN, Sept. 26,<br />

2011, page 7).<br />

The best way for a company to protect<br />

itself, Banholzer says, is to make sure it<br />

has patent protection. Yakov Kutsovsky,<br />

Cabot’s CTO, agrees. “We made a conscious<br />

decision to patent our products in<br />

China,” Kutsovsky says. The commitment<br />

will go a long way to developing robust<br />

patent protection for all companies operating<br />

in China, including Chinese firms,<br />

he says.<br />

A smaller company than Dow, Cabot<br />

has 50 technical service employees at its<br />

Shanghai research center who tweak the<br />

firm’s product line to suit the needs of<br />

customers in China. Having such a team<br />

on the ground in the country is “a major<br />

competitive advantage,” Kutsovsky says.<br />

Although Cabot has not had any IP stolen,<br />

Kutsovsky says, the company takes<br />

a number of precautions in developing<br />

countries. For one, the firm takes steps<br />

to earn employee loyalty and keep turnover<br />

low. It also has protocols in place to<br />

safeguard information when it works with<br />

third parties. And it brings in critical technology<br />

from Europe and the U.S. only on<br />

an as-needed basis—and only with appropriate<br />

security precautions, he says.<br />

Like Dow, DuPont has a large contingent<br />

in developing countries. Combined,<br />

well over 1,000 researchers work at major<br />

DuPont research installations in Shanghai;<br />

Hyderabad, India; and Paulínia , Brazil,<br />

notes DuPont CTO Douglas Muzyka.<br />

These centers develop products for local<br />

markets and act as hubs connected to<br />

DuPont’s global R&D infrastructure.<br />

In China, for instance, local researchers<br />

developed a composite material strengthened<br />

with DuPont’s Kevlar p -aramid fiber<br />

WWW.CEN-ONLINE.ORG 22 FEBRUARY <strong>27</strong>, <strong>2012</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!